Latest Articles

Investing in health is investing in climate resilience, says WHO envoy

24 September 2025

Vanessa Kerry, WHO’s special envoy for climate change and health, says health systems are not just a cost but a driver of prosperity and a frontline defense against climate shocks.

As education fund launches $5B replenishment, a look at the numbers

24 September 2025

The head of the Global Partnership for Education reveals the hosts of their replenishment event.

What role will Africa CDC play in an ‘America First’ global health vision?

24 September 2025

The Trump administration says its future involvement in global health will prioritize country-to-country relationships. The Pan-African public health agency is working to ensure it will play a role in the country’s strategy.

Politics, not economics, driving foreign aid cuts, experts warn

24 September 2025

At Devex Impact House, Jorge Moreira da Silva and Comfort Ero warned that political choices — not shrinking economies — are driving aid cuts, eroding public empathy, and threatening peace building and development worldwide.

Experts: Brain health needs bold investments, not just sympathizers

24 September 2025

Twenty-two nations plan how to keep brains healthy; countries in Europe think the same as their working-age population declines. Other sectors — businesses, academics, and patient groups — need to look at fostering brain health.

UN faces ‘austerity vs. reform’ dilemma as funding crisis deepens

24 September 2025

At a Devex event during the United Nations General Assembly, senior development officials defend the U.N. reform push amid calls for a fundamental rethink of the multilateral institution’s role.

How a USAID exit sparked a private drive to power Africa’s health clinics

25 September 2025

When a USAID electrification program collapsed, a Tanzania pilot proved the model could work — and sparked a private partnership to scale it to 50,000 clinics across Africa.

Opinions

A revolutionary HIV drug won't matter if patients can't afford it

25 September 2025

Opinion: Getting lenacapavir to patients who need it requires engaging health facilities in the private sector. Supply chain startups could make the breakthrough drug more accessible by lowering the costs of distribution to a wider range of facilities.